134 results
8-K
EX-99.1
MOTS
Motus GI Holdings Inc
11 Aug 22
Other Events
8:05am
current expectations and assumptions. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements
8-K
EX-99.1
MOTS
Motus GI Holdings Inc
20 Dec 18
Motus GI Announces Launch of Proposed Follow-on Public Offering
8:02am
Litigation Reform Act of 1995 provides a safe-harbor for forward-looking statements. These statements may be identified by the use of forward-looking
8-K
EX-99.1
MOTS
Motus GI Holdings Inc
27 Jan 21
Motus GI Announces Warrant Exercise Agreement Resulting in Expected Gross Proceeds to the Company of up to $11.0 Million
8:50am
of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to the exercise of the warrants, the use
8-K
EX-99.1
MOTS
Motus GI Holdings Inc
6 Oct 22
Motus GI Granted a U.S. Patent for Prepless Colonoscopy Methods
9:15am
. Forward-looking statements are based on the Company’s current expectations and assumptions. The Private Securities Litigation Reform Act of 1995
8-K
EX-99.1
MOTS
Motus GI Holdings Inc
16 Dec 21
Motus GI Announces U.S. Patent For The Pure-Vu® System's Automatic Self-Purging Features
8:40am
statements. Forward-looking statements are based on the Company's current expectations and assumptions. The Private Securities Litigation Reform Act of 1995
8-K
EX-99.1
nopgqt1jn16u
21 Feb 24
Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract
4:10pm
8-K
EX-99.2
uo1hi tkrioi5
20 Dec 18
Motus GI Announces Launch of Proposed Follow-on Public Offering
8:02am
8-K
EX-99.1
v348r
24 Feb 22
Motus GI Granted 180-Day Extension to Meet NASDAQ Minimum Bid Price Requirement
8:10am
8-K
EX-99.1
lkrck67cy o8pepi5
23 Jun 21
Motus GI Appoints Experienced Financial Biotech Executive, Sonja Nelson, to its Board of Directors and as Chair of Audit Committee
4:10pm
8-K
EX-99.1
5mc0y4wbk smcgqs
12 Mar 20
Entry into a Material Definitive Agreement
8:07am
8-K
EX-99.1
x6x9tcq1qy0vlbmb5
27 Jun 19
Motus GI Announces Proposed Public Offering of Common Stock
8:01am
8-K
EX-99.1
vkppbi77udu 9y7
22 Feb 24
Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds
8:00am
8-K
EX-99.1
yl4ko4k7883yunr
28 Aug 20
Motus GI Announces Pricing of $10 Million Registered Direct Offering Priced At-the-Market
4:36pm
8-K
EX-99.1
9sgsaip
22 May 23
Motus GI Announces $3.5 Million Private Placement
9:14am
8-K
EX-99.1
1w9nmwhl f32m
8 Sep 21
Motus GI Announces Enrollment of Patients at Second Site in the European Union
8:16am
8-K
EX-99.1
ft2erz
11 May 23
Regulation FD Disclosure
7:05am
8-K
EX-99.1
1bqyc5rj92fv8yuneo4
29 Sep 22
Regulation FD Disclosure
9:15am
8-K
EX-99.1
9xc01gu7jmioelq
24 May 22
Motus GI Announces Positive Topline Data From EU Study of the Pure-Vu System
4:10pm
8-K
EX-99.1
cxgbp
24 Oct 22
Motus GI Announces Positive Clinical Data for Pure-Vu EVS in Three Poster
8:40am
8-K
EX-99.1
xj99ms
30 Apr 21
Motus GI Receives FDA Clearance to Market the Pure-Vu® System for Upper GI Endoscopy
10:45am